Login

Livetiles Ltd, led by Matthew Brown, specializes in digital workplace solutions leveraging AI and user-friendly interfaces. 00:10:00

Share On Facebook Share On Twitter

LiveTiles is managed by CEO David Vander.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The Next American Economy: Free Markets and Liberty|Samuel Gregg,Professor,American Institute for Economic Research
00:10:00
The transformative potential of cell therapy for cancer treatment and highlights recent clinical advancements and team expertise | Jennifer Chow, CEO, Chimeric Therapeutics Ltd.
00:10:00
startup projects to experience reports should be shared by both industry|Michael Nogen,Managing Partner,Overton Venture Capital
00:10:00
Atlas Energy to build a 42 mile conveyor belt | John Turner, CEO, Atlas Energy Solutions IncAESI:NYQ
00:10:00
Avaada’s Vineet Mittal Discusses Renewable Energy at ETRenewableEnergy Conclave | Vineet Mittal , Chairman , Avada Group.
00:10:00
Behind the Scenes: JIC's Stock Selection Process Explained
00:10:00
Bessemer supports founders and CEOs from their early days through every stage of growth|Tess Hatch,Partner,Bessemer Venture Partners
00:10:00
Leon Devaney, Managing Director and CEO of Central Petroleum, discussed the company results and outlook with the Morgans network|Leon Devaney , CEO AT Managing Director & Chief Executive Officer Central Petroleum Ltd
00:10:00
Interview with Chesapeake Gold Corp's Interim CEO John Paulos at the 1-2-1 Mining Investment New York Event.
00:10:00
Sebastien Paré, CEO of VIQ Solutions, engaged in a pivotal conversation with Bob Power on crucial industry matters.
00:10:00
Jean, CEO of Wellington: A Journey of Leadership and Legacy| Jean M. Hynes, CEO , Wellington Management Company.
00:00:00
Jerome D. Jabbour Chief Executive Officer, Matinas BioPharma Holdings Inc

© 2017 - Neuhu+